ArticleFrontiers in public health2026
Public health risk assessment of rodent-driven hantavirus spillover in Europe using a stochastic delay model.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hantavirus is a rodent-borne zoonotic disease in which rodents serve as the primary reservoir, while humans acquire infection through spillover exposure. To better understand the effects of environmental variability and delayed disease dynamics on transmission, this study develops a stochastic delay differential model that incorporates biologically relevant features of hantavirus spread. Methods: An SIR-SIR transmission framework is formulated for interacting rodent and human populations. The deterministic model is extended by incorporating Brownian stochastic perturbations, discrete time delays, and exponential delay-survival effects to capture incubation, survival, and environmental uncertainty. The qualitative properties of the model, including positivity, boundedness, feasibility, and well-posedness, are established. Disease-free and endemic equilibria are derived, and both deterministic and stochastic reproduction numbers are obtained. Extinction and persistence conditions are investigated using stochastic threshold analysis. Numerical simulations are carried out using the Euler-Maruyama, stochastic Runge-Kutta, and stochastic nonstandard finite difference (SNSFD) methods. Results: The analysis shows that hantavirus persistence is primarily governed by rodent-to-rodent transmission, whereas human infections arise through spillover from infected rodents. Stochastic perturbations and delay-survival effects reduce the effective reproduction threshold under certain conditions and can promote disease extinction. Theoretical findings are supported by numerical simulations, which demonstrate that all three numerical methods produce consistent solutions for small time steps. However, the SNSFD scheme preserves positivity and exhibits superior numerical stability under larger time steps and stronger stochastic perturbations. Reported hantavirus updates from 2026 are incorporated to motivate the model and emphasize the continued importance of reservoir-driven transmission dynamics. Discussion: The proposed stochastic delay model provides a mathematically rigorous and biologically realistic framework for studying hantavirus transmission. The results highlight that controlling infection within the rodent reservoir is the most effective strategy for reducing disease persistence and limiting human spillover. The improved stability of the SNSFD method also makes it a suitable computational approach for simulating stochastic epidemic systems with delays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.